32.9 C
Vientiane
Saturday, July 5, 2025
spot_img
Home Blog Page 1631

Laos Readies to Chair ASEAN, Host Regional Meetings

Laos Aids Timor-Leste in Building Capacity to ASEAN Accession 
Flags from the bloc's member countries. (Photo: Pixabay)

As Laos gears up to assume the chairmanship of the Association of Southeast Asian Nations (ASEAN) in 2024, the country is set to host a series of regional meetings, including the Foreign Ministerial Retreat on 28-29 January in the historic city of Luang Prabang.

X-PITCH 2023 Global Winners Announced

Celebrating Innovation Excellence in Deeptech Startups

SINGAPORE – Media OutReach – 14 November 2023 – X-PITCH, known as the X Games for Startups, concluded its 2023 edition on November 9, spotlighting ten finalists chosen from over 3,000 startups worldwide. The Finals, held at the prestigious National Gallery Singapore, saw a packed audience eagerly witnessing the convergence of cutting-edge ideas and entrepreneurial brilliance. Four deeptech startups emerged as award winners, set to receive a total investment of US$1 million.

PR_231114_pic.jpg
Pitch on the Singapore River bumboats

The competition featured unconventional semi-finals conducted on Singapore River bumboats – a groundbreaking first for the global startup arena. K. Yu, Organizing Committee Chair of X-PITCH 2023 and Founding Partner of XCEL NEXT, expressed his enthusiasm for the event’s continual evolution, stating, “At X-PITCH, we redefine startup competition every year, transforming it into the X Games of innovation. From skyscraper’s elevator to self-driving car and MRT in previous editions, we’ve always pushed the boundaries. This year, we took it to the water! X-PITCH is not just an event, but a journey into the extraordinary.”

X-PITCH 2023 extends its heartfelt gratitude to the supporting organizations A*StartCentral, Enterprise Singapore, and IMDA. The success of the event was made possible by the collaboration with the co-host e27 and co-organizers Block71 Singapore, BSSC, Cool Japan Fund, DOST-PCIEERD, HKSTP, HUB.ID, KOVA, MDEC, TA, TINVA, TusStar, and VITTBI. Special recognition is also given to sponsors AIOX Apex Angel Fund, Foxconn Technology, Media OutReach Newswire, Quan Ding Consulting, and Yulon Motor.

This year’s X-PITCH once again exemplifies its commitment to fostering innovation and providing a platform for outstanding startups to shine on a global stage. Congratulations to all the winners for their exceptional contributions to the world of deeptech.Hashtag: #xpitch #deeptech #startupcompetition

The issuer is solely responsible for the content of this announcement.

About X-PITCH

X-PITCH is an iconic startup event in Asia, and probably the most challenging pitch contest in the world. Known as the “X Games for Startups”, founders go through a series of pitch challenges to win investments, awards, and exposure. Official website:

Eu Yan Sang International Invests in Chien Chi Tow Healthcare, Strengthening Its Presence in Traditional Chinese Medicine

SINGAPORE – Media OutReach – 14 November 2023 – Eu Yan Sang International (EYSI), one of Asia’s leading Health & Wellness companies with a strong heritage in Traditional Chinese Medicine (TCM), is pleased to announce that it has made a substantial investment into Chien Chi Tow Healthcare Pte Ltd (CCTH). CCTH provides TCM services and products through Chien Chi Tow, a Singapore-based, 50-year-old heritage brand and pre- and post-partum wellness services through its subsidiary, Madam Partum.

(right to left): Dominic Wong (Group CEO, EYSI), Richard Eu (Chairman, EYSI), Mrs Lim, Master Lim Choon Huat (Founder, CCTH), Lim Kim Yen (founder, Madam Partum), Richie Eu (MD, Mergers & Acquisitions, EYSI)
(right to left): Dominic Wong (Group CEO, EYSI), Richard Eu (Chairman, EYSI), Mrs Lim, Master Lim Choon Huat (Founder, CCTH), Lim Kim Yen (founder, Madam Partum), Richie Eu (MD, Mergers & Acquisitions, EYSI)

EYSI’s decision to invest in CCTH reflects its ongoing ambition and commitment towards expanding quality health and wellness offerings for its consumers. Several of its representatives will also join CCTH’s Board of Directors in furtherance of this investment, reflecting EYSI’s intention to actively participate in the growth of these brands as part of its expanded portfolio.

This will bring together EYSI’s best-in-market product innovation capabilities with Chien Chi Tow’s and Madam Partum’s recognition and renown with customers, bolstering each companies’ respective standing in the TCM and Health & Wellness space.

The combination of EYSI’s rich history and trailblazing healthcare solutions with Chien Chi Tow’s expertise in both Tuina (musculoskeletal relief) and perinatal solutions for women under the Madam Partum brand are also expected to further reinforce EYSI’s leading position in Singapore’s Health and Wellness industry. EYSI’s highly trusted products and formulations will be made available at Chien Chi Tow and Madam Partum clinics, further backed by EYSI’s capabilities to deliver enhanced service treatments. Likewise, EYSI’s clinic and retail network will benefit from a further boost in its already diversified offerings.

The investment will also augment EYSI’s extensive footprint, incorporating CCTH’s outlets into its roster of over 180 retail outlets throughout Asia and 30 TCM clinics. These include 2 integrative health clinics under the One Wellness Medical brand, a unique East-West model that draws on the benefits of both conventional general practices (GP) and complementary TCM services.

“Eu Yan Sang has consistently championed the modernization of TCM and its accessibility to consumers. By welcoming Chien Chi Tow Healthcare and Madam Partum into our fold, we are strengthening our already market-leading clinic business with more specialized and targeted clinical services.” Mr Dominic Wong, Group CEO of EYSI, said.

Founded in 1969 by Master Lim Choon Huat, Chien Chi Tow started as a martial arts institute, later leveraging its roots in TCM philosophies to formulate a holistic system of Tuina techniques. In 2017, the brand launched Madam Partum under the leadership of his daughter, Ms Lim Kim Yen, providing wellness offerings geared towards pre-partum and post-partum care. Madam Partum’s comprehensive suite of services has shaped the brand into an essential partner for mothers on their perinatal journey.

“Joining forces with Eu Yan Sang International, a company I have long admired, is both an honour and a pivotal moment for Chien Chi Tow Healthcare. This collaboration not only validates our decades of dedication to TCM but also opens up a horizon of new possibilities. We are enthusiastic about bringing our specialized expertise in our services and holistic TCM treatments to a wider audience, and I firmly believe that together with EYSI, we can redefine the future of TCM in Asia,” Master Lim Choon Huat, founder of Chien Chi Tow, said.

“We are delighted to embark on this exciting path with Eu Yan Sang International Ltd. Our journey at Madam Partum has always been about empowering mothers and providing holistic TCM-based solutions during the crucial pre- partum and post-partum phases. This partnership with Eu Yan Sang aligns perfectly with our mission to make high-quality TCM healthcare more accessible. Together, we are able to bring our specialized care to even more mothers and families,” Ms Yen Lim, founder of Madam Partum, expressed.

Both Chien Chi Tow and Madam Partum will retain their individual brand identities. The investment embodies EYSI’s vision to strike strategic partnerships with exciting companies that feature profound domain expertise, exceptional talents, and a strong brand identity, particularly in TCM and Health & Wellness categories.
Hashtag: #EuYanSang

The issuer is solely responsible for the content of this announcement.

Eu Yan Sang International

Eu Yan Sang is a well-established company that has been providing accessible healthcare based on Traditional Chinese Medicine (TCM) since 1879. Its origins can be traced back to a small medical hall in Gopeng, Perak, Malaysia, where it aimed to help tin mine workers overcome opium addiction through TCM remedies.

Throughout the years, Eu Yan Sang has become a trusted brand and well-known for its high quality and standards. It is a leading TCM health and wellness company in Asia, blending medical science with TCM wisdom to create innovative healthcare solutions. The company’s mission is centered around “caring for mankind”.

Eu Yan Sang places significant importance on maintaining stringent quality control across its entire supply chain. This encompasses sourcing raw materials, manufacturing and distributing finished products, and providing treatments. The company offers a diverse range of products, including over 1,000 types of herbal ingredients, proprietary Chinese medicine, health supplements, and foods for daily health maintenance. Eu Yan Sang has also a pioneer in modernizing classical TCM formulas, making them more convenient through products like ready-to-drink soup packs, American Ginseng tea bags, and bottled bird’s nests.

As of Oct 2023, Eu Yan Sang has built an extensive distribution network comprising over 180 Eu Yan Sang retail outlets in Singapore, Malaysia, Hong Kong, Macau & Mainland China. Customers can purchase its products through various channels, such as the company’s website www.EuYanSang.com, selected online marketplaces, and physical stores located in airports, in-flight stores, drugstores, pharmacies, medical halls, supermarkets, convenience stores, and hospitals worldwide. Additionally, Eu Yan Sang operates a chain of over 30 TCM Clinics and integrative clinics in Singapore, Malaysia, and Hong Kong. These clinics are staffed by licensed TCM practitioners who are meticulously selected for their expertise. Furthermore, the company operates a food and beverage outlet in Malaysia.

Chien Chi Tow

Established in 1969 by Master Lim Choon Huat, Chien Chi Tow began as a martial arts institute. Over the years, we observed and mastered the commonalities between the disciplines of martial arts and healing arts, allowing us to bridge the knowledge and skills of both. This paved the way for us to become a renowned TCM brand in Singapore, offering a comprehensive suite of holistic solutions, including tuina and acupuncture treatments.

A new brand, Madam Partum was born in 2017, drawing on the expertise of the existing Chien Chi Tow team, Yen relentlessly researched the TCM tuina techniques and herbal knowledge to provide a complete suite of products and services for mothers going through the perinatal journey. Madam Partum is currently the leading TCM Pre and Postpartum specialist care center, helping mothers achieve a complete and wholesome recovery journey through their holistic programme.

OCBC Cycle Fun Space at Singapore Festival 2023 on 18-19 November

Calling families and kids interested in Singaporean food and culture

HONG KONG SAR – Media OutReach – 14 November 2023 – OCBC Bank (Hong Kong) Limited (“OCBC Hong Kong”) presents OCBC Cycle Fun Space at Singapore Festival 2023 on 18-19 November 2023 at Central Market, joining hand with our trusted partner The Singapore Chamber of Commerce Hong Kong.

A3 Poster_Output.jpg

As a Bank that advocates Singaporean culture and sustainable and healthy lifestyle, OCBC Hong Kong invites families and kids to participate in some exciting activities including Singapore traditional games, ‘SG-HK’ virtual bike challenge and balance bike experience. On top, anyone who pre-registers for Singapore Festival 2023 can get freebies at the on-site reception counter, and participate in activities such as face painting, balloon twister and others for free!

OCBC Cycle is an annual mass participation cycling game event organised by OCBC Group in Singapore attracting more than 9,000 passionate cyclists every year. It aims to be a safe cycling platform for riders across all cycling proficiencies. OCBC Hong Kong brings the Group’s passion for cycling to the local community, solidifying its “One Group” approach.

Save the date and see you there!

OCBC Cycle Fun Space
Date: 18 – 19 November 2023
Time: 12 noon to 10 pm
Location: Singapore Festival 2023

Central Market, Ground Floor

OCBC Booth & OCBC Cycle Fun Space

Central Market, Ground Floor (G08 booth) and 1/F Event Space

Register: https://events.singaporeglobalnetwork.gov.sg/singapore-festival-hong-kong-2023-kjxhf

Hashtag: #OCBCHongKong

The issuer is solely responsible for the content of this announcement.

About OCBC

OCBC is the longest established Singapore bank, formed in 1932 from the merger of three local banks, the oldest of which was founded in 1912. It is one of the world’s most highly-rated banks, with Aa1 by Moody’s and AA- by both Fitch and S&P. Recognised for its financial strength and stability, OCBC is consistently ranked among the World’s Top 50 Safest Banks by Global Finance and has been named Best Managed Bank in Singapore by The Asian Banker.

OCBC is the second largest financial services group in Southeast Asia by assets. The Group offers a broad array of commercial banking, specialist financial and wealth management services, ranging from consumer, corporate, investment, private and transaction banking to treasury, insurance, asset management and stockbroking services.

OCBC’s private banking services are provided by its wholly-owned subsidiary Bank of Singapore, which operates on a unique open-architecture product platform to source for the best-in-class products to meet its clients’ goals. Its insurance subsidiary, Great Eastern Holdings, is the oldest and most established life insurance group in Singapore and Malaysia. Its asset management subsidiary, Lion Global Investors, is one of the leading asset management companies in Southeast Asia.

The Group’s key markets are Singapore, Malaysia, Indonesia and Greater China. It has more than 410 branches and representative offices in 19 countries and regions.

For more information, please visit to learn more about OCBC Hong Kong.

Kenanga Investment Bank Champions Fraud Prevention and Detection in its 7th Annual Fraud Awareness Campaign

KUALA LUMPUR, MALAYSIA – Media OutReach – 14 November 2023 – Kenanga Investment Bank Berhad (“Kenanga“) proudly launches its seventh annual Fraud Awareness Week (“FAW“), reaffirming its ongoing dedication to combatting fraudulent activities and promoting ethical business practices.

Kenanga Investment Bank champions fraud prevention and detection in its 7th annual fraud awareness campaign.
Kenanga Investment Bank champions fraud prevention and detection in its 7th annual fraud awareness campaign.

Under the theme of “Embracing Disruption, Pioneering Change, Unwavering Integrity,” this year’s FAW initiative functions as a unifying platform, drawing in a diverse group of internal and external stakeholders to collaboratively bolster the fight against fraud, bribery, and corruption across all sectors.

Held in conjunction with the International FAW of the Association of Certified Fraud Examiners (“ACFE“), FAW stands as a manifestation of our unwavering commitment to combat fraud. This comprehensive month-long fraud awareness campaign features a range of virtual programmes, including the Opening Ceremony and the FAW Games, all while aligning with the United Nations Global Compact’s 10th Principle, which emphasises on the necessity for businesses to actively combat corruption in all its forms.

The FAW Games, featuring interactive anti-fraud games and quizzes, witnessed a surge in participation, marking a 16.5% increase compared to the previous year, from 376 to 438 participants who have registered. The event attracted a diverse audience, including representatives from various regulatory bodies, public listed companies, professional entities, and Kenanga’s vendors, such as Bursa Malaysia Berhad, Securities Commission Malaysia, Securities Industry Development Corporation, Kumpulan Wang Simpanan Pekerja, Institute of Corporate Directors Malaysia, Nestle Products, SP Setia, Petronas, Leadwomen, EY Malaysia as well as other notable organisations.

Notably, the event also witnessed participation from organisations based in Singapore, Indonesia, United Arab Emirates, and South Africa, including Singapore Exchange LTD, Indonesia Stock Exchange, Consultero Fzco Dubai, Western Cape Government, and several others.

During the virtual opening ceremony, Tan Sri Dato’ Seri Panglima Haji Azam bin Baki, the Chief Commissioner of Malaysian Anti-Corruption Commission (“MACC“), expressed, “It is my hope that Kenanga’s Fraud Awareness Week would serve as a platform where stakeholders come together, share insights and collectively identify effective solutions to prevent fraud and corruption. This is also in-line with the MACC’s goals of optimising collaborative efforts of all organisations to exchange information, best practices, and experiences aimed at enhancing governance.”

“Kenanga’s Fraud Awareness Week demonstrates our ongoing commitment to integrity and combating fraud across diverse industries. By fostering vigilance and collaboration, we aim to empower a community dedicated to ethical practices, ensuring a secure environment for all stakeholders,” remarked Datuk Chay Wai Leong, Kenanga Investment Bank Berhad.

“In an era where technological advancements and digital transformations continue to reshape industries, the fight against fraud has taken on new dimensions. Through Kenanga’s Fraud Awareness Week, we strive to reinforce our vigilance and preparedness, working alongside regulators and stakeholders to strengthen our defenses against emerging cyber threats. By empowering our teams and the wider community, we remain dedicated to safeguarding our operations and stakeholders from the evolving risks of fraudulent activities,” added Maheswari Kanniah, Group Chief Regulatory and Compliance Officer of Kenanga Investment Bank Berhad.

“Fraud remains a persistent threat to businesses and communities worldwide, and the need for increased vigilance and education is more critical than ever. We applaud Kenanga’s dedication to raising awareness and nurturing a culture of integrity. Through active participation in initiatives like the Fraud Awareness Week, Kenanga is proactively combating fraudulent activities and contributing to the development of a more resilient business landscape,” said John Gill, President of the Association of Certified Fraud Examiners.

Complementing this year’s FAW is a Talk Session in collaboration with the esteemed Faculty of Law of the University of Malaya (“UM“). This strategic initiative serves as a pivotal component of Kenanga’s social outreach programme, aligning with the ESG framework, aimed at enhancing the awareness of fraud prevention and detection within the local community, particularly among the students of UM’s Law Faculty. Alongside the customary FAW initiatives, this programme underscores Kenanga’s unwavering commitment to fostering governance culture and transparency throughout the organisation and within the community by prioritising ethical conduct and collective vigilance against fraudulent activities.

To view the 2023 opening ceremony and learn more about FAW, please visit: https://www.kenanga.com.my/faw.

Hashtag: #kenaga #fraudawareness #faw

The issuer is solely responsible for the content of this announcement.

Kenanga Investment Bank Berhad (197301002193 (15678-H))

Established for 50 years, Kenanga Investment Bank Berhad (“The Group“) is a financial group in Malaysia with extensive experience in equity broking, investment banking, treasury, Islamic banking, listed derivatives, investment management, wealth management, structured lending and trade financing.

An innovative and established home-grown brand, the Group’s digital ambition includes building a robust digital ecosystem that meets the needs of its clients and businesses. Some of its game-changing products include Malaysia’s fully online digital stockbroking platform Rakuten Trade and a fully A.I. robo-advisor, Kenanga Digital Investing. The Group also launched Malaysia’s first securities broking e-wallet, Kenanga Money, paved the way in AI-led Quan and algorithmic trading, kick-started a revolutionary supply chain financing solution for SMEs and made inroads into the digital assets space through its investment in Tokenize Technology (M) Sdn.Bhd.

The Group has garnered a host of awards and accolades reflecting its strong market position. It was awarded Highest Returns to Shareholder Over Three Years, Highest Growth in Profit After Tax Over Three Years and Highest Return on Equity Over Three Years by The Edge Malaysia Centurion Club in the Financial Services Category, Best Overall Equities Participating Organisation (Champion), Best Retail Equities Participating Organisation (Champion), and Best Online Retail Participating Organisation (Champion), as well as Best Institutional Derivatives Trading Participant (Champion) and Best Overall Derivatives Trading Participant (1st Runner Up) in the Bursa Excellence Awards 2022. The Group was also accorded the title of Best House, South and Southeast Asia Award in the SRP Asia Pacific Awards 2022.

The Group continues to be a regular and repeat recipient of distinguished industry accolades, such as the Lipper, Fundsupermart and Morningstar awards. Rakuten Trade, Malaysia’s first fully digital securities broker in 2017 via a joint venture with Japanese fintech giant Rakuten Securities Inc was also named Malaysia’s Digital Experience of the Year – Brokerage at the Asian Experience Awards 2022. For its continued efforts towards community outreach and employee volunteerism, the Group was awarded the coveted Bank of the Year Award for Environmental, Social & Governance Excellence, as well as Long-Standing Excellence in Sustainability at Sustainability & CSR Malaysia Awards 2022. The Group is also a Participant of the United Nations Global Compact and adheres to its principle-based approach to responsible business.

Today, Kenanga Investment Bank Berhad is an award-winning leading independent investment bank in the country with a continuous commitment towards driving collaboration, innovation, digitalisation and sustainability in the marketplace.

This Press Release was issued by Kenanga Group’s Marketing, Communications & Sustainability Department.

Vantage Data Centers Announces New Senior Leadership Appointments in Asia Pacific

Industry veterans join as president and CFO to drive further growth to keep pace with customer demand

DENVER, USA and SINGAPORE – Media OutReach – 14 November 2023 – Vantage Data Centers, a leading global provider of hyperscale data center campuses, today announced the appointment of new executive leadership in APAC to support the company’s expanding regional presence. Raymond Tong has joined Vantage as President, APAC to oversee Vantage’s business including expansion, operations and strategy in the Asia Pacific market. Tong will work closely with incoming Chief Financial Officer, APAC Joel Cheah who leads Vantage’s APAC finance and accounting teams.
Tong brings more than 25 years of business and management experience to Vantage’s APAC business. He joins the company from SUNeVision Holdings Ltd., the largest data center operator in Hong Kong, where he served for five years as chief executive officer and executive director of the board. Tong’s rich experience leading teams to scale operations and deliver key business outcomes is well suited to spearhead Vantage’s growth strategy. Prior to his time at SUNeVision Holdings, Tong held executive-level roles at several companies including Maxim’s Group and China Resources Enterprise (CRE) Ltd.
As an experienced and award-winning financial executive with a focus on real estate investment trusts (REITs), Cheah brings more than 15 years of experience navigating finance, tax regulations, capital markets and investor relations. Prior to joining Vantage, he spent more than four years serving as CFO for Elite Commercial REIT Management Pte Ltd, manager of Elite Commercial REIT, where he helped lead the company’s initial public offering (IPO) and oversaw the maiden acquisition of 58 assets for a total of £212.5 million ($257.6 million). He also previously held senior finance roles at two other listed S-REITs.
Both Tong and Cheah will be based in Singapore at the newly expanded headquarters for the Vantage APAC region.
Jeff Tench will continue in his role as executive vice president of North America and APAC and will collaborate with Tong and Cheah to advance the company’s continued growth.
“As Vantage strengthens our senior team, I look forward to working closely with Raymond and Joel to pursue new areas of growth and meet customer demand across APAC,” said Tench. “Our growing presence in the region provides a key opportunity for us to drive the creation of digital hubs to support technological advancements, and I am excited to tap into their expertise to further grow our APAC platform.”
Vantage’s APAC business has seen a significant increase in its overall footprint in the last 12 months. The company currently has seven campuses across the region that are either operational or under development. For more information on the company’s campuses in the Asia-Pacific region, please visit https://vantage-dc.com/data-center-locations/apac/.
###

For imagery of Mr. Tong and Mr. Cheah, please download here.

Hashtag: #VantageDataCenters

The issuer is solely responsible for the content of this announcement.

About Vantage Data Centers

Vantage Data Centers powers, cools, protects and connects the technology of the world’s well-known hyperscalers, cloud providers and large enterprises. Developing and operating across five continents in North America, EMEA and Asia Pacific, Vantage has evolved data center design in innovative ways to deliver dramatic gains in reliability, efficiency and sustainability in flexible environments that can scale as quickly as the market demands.

For more information, visit

Daiken Biomedical’s Lutein Secures 2023 International A.A. Clean Label Certification

Human Trials Show 190% Increase in Eye Hydration

HONG KONG SAR – Media OutReach – 14 November 2023 – Daiken Biomedical, a prominent international health food manufacturer headquartered in Taipei, is committed to creating safe, sensible, and pure health foods made with high-quality raw materials. Daiken Biomedical maintains complete transparency about its ingredients, and its products have earned numerous international certifications from the authorities in recent years. In 2023, they achieved the remarkable milestone of receiving 13 Anti-Additive Clean Label Certifications, which speaks volumes about their dedication to ensuring the purity of the ingredients used for their products.

Daiken Biomedical_EN_hk_3.png

Certified by Anti-Additive Clean Label Certification

The A.A. Clean Label (ANTI-ADDITIVE CLEAN LABEL) Certification is a rigorous global standard for certifying products free from additives. Products that receive this certification are recognised for their safety, including the absence of harmful substances and compliance with environmental and health regulations throughout their production and packaging processes.

Daiken Biomedical’s Lutein Recognised with the A.A. Clean Label Certification in 2023

In 2023, Daiken Biomedical’s flagship product, Lutein, was also certified by the A.A. Clean Label Certification in recognition of its purity and high quality. Additionally, Daiken Biomedical conducted extensive human clinical trials in partnership with international teaching hospitals and medical schools. After 18 months, Lutein demonstrated significant benefits in protecting eye health; research showed that within just 28 days, Lutein could increase the body’s lutein concentration by 520%, significantly enhancing eye moisture by 190%. These impressive results indicate Daiken Biomedical’s dedication to creating safe and effective health products. These findings were shared at the 22nd International Congress of Nutrition in Tokyo, Japan, in 2022, and the product has been awarded the Monde Selection Grand Gold Quality Award for two consecutive years, reflecting Daiken Biomedical’s exceptional commitment to health product quality.

Daiken Biomedical’s Lutein is made up of a ‘Golden Formula’ containing seven ingredients, including FloraGLO® Lutein and ZeaONE® Zeaxanthin, both backed by a wealth of research and approved by The European Food Safety Authority (EFSA). It also includes MaquiBright® Maqui Berry and BS7® Bilberry, which are rich in anthocyanins, the potent antioxidant AstaZine® Astaxanthin, flaxseed oil, and vitamin E. These ingredients work together to comprehensively support vision and eye health.

Ophthalmologist Recommends Three Steps to Select Top-Tier Lutein for Effective Dry Eye Relief

With numerous eye care products like lutein available on the market, how should consumers choose the right one? Ophthalmologist Dr. Yun-Chen Chen, from Taiwan, recommends three selection principles to determine the most effective lutein supplements for combating dry and tired eyes in today’s lifestyle, characterised by extensive use of electronic devices that rapidly depletes lutein. These guidelines help ensure the body receives the necessary nutrients.

Principle 1: Free-Form Lutein and the Optimal Ratio

Health supplements contain lutein in two forms: free-form and esterified form. Dr. Chen explains that esterified lutein requires digestive enzymes for absorption and is best taken with fats, which may not be suitable for individuals with digestive issues to consume. The molecular weight of free-form lutein is roughly half that of the esterified form; as a result, it is typically considered by the academic community to have a better absorption rate. The “Golden Ratio” refers to the optimal ratio of 10 mg of lutein to 2 mg of zeaxanthin, as determined by the five-year AREDS2 study conducted by the National Eye Institute in the U.S., to be the most beneficial for the human body. Daiken Biomedical’s Lutein is created in collaboration with the U.S.-based Kemin Industries, which possesses multiple patented technologies, to produce a product with the golden ratio of FloraGLO® free-form Lutein and ZeaONE® free-formZeaxanthin used in U.S. NIH clinical trials. Furthermore, FloraGLO® Lutein is the most effective ingredient available on the market, supported by the research. Clinical data demonstrated a 520% increase in the body’s lutein content after 28 consecutive days of consuming FloraGLO® Lutein.

Principle 2: The Benefits of Complexes of Lutein with Maqui Berry and Bilberry as Ingredients

In addition to lutein, Dr. Yun-Chen Chen suggests that combining lutein products with complex ingredients such as anthocyanins and astaxanthin can help maintain long-lasting moisture and brightness of the eyes. MaquiBright® Maqui Berry assists in regulating tear gland function and relieving dry eye symptoms, while BS7® Bilberry provides excellent antioxidant benefits, maintaining normal eye pressure and preventing night blindness. AstaZine® Astaxanthin helps reduce eye fatigue and pressure, which is beneficial for glaucoma care. Flaxseed oil and vitamin E are also excellent supporting ingredients, enhancing the body’s absorption of lutein.

Principle 3: International Awards and Certifications Indicate Superior Product Quality

Looking for high-quality lutein products with guaranteed effectiveness? Dr. Yun-Chen Chen recommends evaluating whether the product has received any awards or certifications. Daiken Biomedical’s Lutein, for example, has been awarded the Monde Selection Grand Gold Quality Award for two consecutive years after a thorough evaluation by over a hundred global experts. In terms of certification and testing, the raw materials for Lutein are sourced from American Kemin Industries, a company with 16 global patents covering seeds, production processes, and effectiveness. Additionally, it has been certified by Eurofins, an international third-party testing service provider, for being free of the Hepatitis A virus. This certification ensures food safety and instils trust in consumers. Dr. Chen also notes that lutein’s health benefits will not come into effect immediately; consistent supplementation after meals for 2 to 4 months or more is necessary for the benefits to take effect.

The biomedical research team at Daiken Biomedical, consisting of doctors and medical experts specialising in biotechnology from the United States, Japan, and Taiwan, stays true to the mottos: “safety and high quality” and “always deliver sensible results.” The team is committed to developing safe and effective health foods for you and your family. Daiken Biomedical invests over a million dollars annually in evaluation and inspection and is 100% transparent about its ingredients. Their products have repeatedly received certifications from international authorities, including 13 products, such as Lutein, that have been certified as additive-free and a total of twenty-two gold awards and trophies from Monde Selection for Many consecutive years. In the future, Daiken Biomedical will continue being dedicated to creating safe, pure, and sensible health food to help the community lead healthier lives.

The biomedical research team at Daiken Biomedical, consisting of doctors and medical experts specialising in biotechnology from the United States, Japan, and Taiwan, stays true to the mottos: “safety and high quality” and “always deliver sensible results.” The team is committed to developing safe and effective health foods for you and your family. Daiken Biomedical invests over a million dollars annually in evaluation and inspection, and is 100% transparent about their ingredients. Their products have repeatedly received certifications from international authorities, including eight products that have been certified as additive-free and a total of twenty-two gold awards and trophies from Monde Selection for many consecutive years. In the future, Daiken Biomedical will continue being dedicated to creating safe, pure, and sensible health food to help you and your family lead healthier lives.

Hashtag: #DaikenBiomedical

The issuer is solely responsible for the content of this announcement.

EquitiesFirst Podcast Series II, Episode 3: Exploring Entrepreneurship in Asia-Pacific

HONG KONG SAR – Media OutReach – 14 November 2023 – EquitiesFirst, in collaboration with The Economist Impact, is proud to present Episode 3 of our enlightening Podcast Series II: “Unlocking Entrepreneurship in Asia-Pacific.” This episode embarks on an insightful journey through the vibrant startup ecosystem emerging across the region, illuminating the pivotal role of EquitiesFirst equities-based investment in nurturing the seeds of innovation and growth.

EquitiesFirst Financing: Opportunities in Asia-Pacific’s Startup Landscape
This episode delves deep into the factors contributing to the growing startup landscape in Asia-Pacific. From the rapid advancement in communication and transportation infrastructures to the demographic shifts signifying an expanding consumer class and digitally savvy workforce, these elements are reshaping the future of business in the region. Along with EquitiesFirst equities-based financing solutions, these factors could play a part in supporting the startup climate, particularly in sectors like fintech, e-commerce, and healthtech.

EquitiesFirst Risk Management: Navigating an Evolving Financial Landscape
This episode also examines the dip in Asia-Pacific’s venture capital to a six-year low in early 2023, the support from accelerators and the public sector, and the strategies to mitigate talent gaps. Anchored by the expertise of EquitiesFirst risk management, speakers will share their insights and perspectives on how startups and investors could maneuver through these evolving financial challenges.

EquitiesFirst Partnership: A Commitment to Insightful Engagement
Through a partnership with The Economist Impact, EquitiesFirst reaffirms its commitment to delivering insightful discussions on investment trends and opportunities. The collaboration seeks to contribute to informed decision-making for investors and stakeholders interested in the Asia-Pacific equities landscape.

EquitiesFirst remains engaged in the dialogue around risk management and strategic investment, leveraging its experience to contribute to the broader conversation about the future of financing and investment in a diverse and multifaceted region like Asia-Pacific.

Hashtag: #EquitiesFirst

The issuer is solely responsible for the content of this announcement.

About Equities First Holdings

Founded in 2002, EquitiesFirst is a global investor specializing in long-term equities-based financing. EquitiesFirst’s approach overcomes traditional limitations and redefines the financing experience through providing efficient access to capital for listed companies, entrepreneurs and investors against publicly traded securities. The total value of loans transacted is more than US$4.5 billion as of January 2023.

Headquartered in Indianapolis, USA, EquitiesFirst maintains an international footprint of twelve offices in eight countries, including the United States, United Kingdom, Spain, China (Hong Kong, Shanghai and Beijing), South Korea, Thailand, Singapore and Australia (Sydney, Perth and Melbourne). EquitiesFirst is licensed and/or registered in all jurisdictions where required.

EquitiesFirst is the pioneer of Progressive Capital – a partnership approach to investment, rooted in respect, mutual interest and understanding. EquitiesFirst delivers liquidity solutions that are vital, transformative and move partners forward.

For more information, please visit .

Disclaimer
This Document is intended solely for accredited investors, sophisticated investors, professional investors, or otherwise qualified investors, as may be required by law or otherwise, and it is not intended for, and should not be used by, persons who do not meet the relevant requirements. The content provided herein is for informational purposes only and is general in nature and not targeted to any specific objective or financial need. The views and opinions expressed in this Document have been prepared by third parties and do not necessarily reflect the views and opinions of EquitiesFirst. EquitiesFirst has not independently examined or verified the information provided herein, and no representation is made that it is accurate or complete. Opinions and information herein are subject to change without notice. The content provided does not constitute an offer to sell (or solicitation of an offer to purchase) any securities, investments, or any financial products (“Offer”). Any such Offer shall only be made through a relevant offering or other documentation which sets forth its material terms and conditions. Nothing contained in this Document shall constitute a recommendation, solicitation, invitation, inducement, promotion, or offer for the purchase or sale of any investment product by First Holdings, LLC or its subsidiaries (collectively, “EquitiesFirst”), nor shall this Document be construed in any way as investment, legal, or tax advice, or as a recommendation, reference, or endorsement by EquitiesFirst. You should seek independent financial advice prior to making an investment decision about a financial product.

This Document contains the intellectual property of EquitiesFirst in the United States and other countries, including, without limitation, their respective logos and other registered and unregistered trademarks and service marks. EquitiesFirst reserves all rights in and to their intellectual property contained in this Document. The Document should not be distributed, published, reproduced or otherwise made available in whole or in part by recipients to any other person and, in particular, should not be distributed to persons in any country where such distribution may lead to a breach of any legal or regulatory requirement.

EquitiesFirst make no representation or warranty with respect to this Document and expressly disclaim any implied warranty under law. You acknowledge that EquitiesFirst is not liable under any circumstances for any direct, indirect, special, consequential, incidental, or punitive damages whatsoever, including, without limitation, any lost profits or lost opportunity, even if EquitiesFirst has been advised of the possibility of such damages.

EquitiesFirst makes the following further statements that may be applicable in the stated jurisdiction:

Australia: Equities First Holdings (Australia) Pty Ltd (ACN: 142 644 399) holds an Australian Financial Services Licence (AFSL Number: 387079). All rights reserved.

The information contained on this Document is intended for persons located in Australia only and classified as a Wholesale Client only as defined in Section 761G of the Corporations Act 2001. The distribution of information to persons outside this criteria may be restricted by law and persons who come into possession of it should seek advice and observe any such restriction.

The material contained in this Document is for information purposes only and should not be construed as an offer or solicitation or recommendation to buy or sell financial products.

The information contained in this Document is intended to be general in nature and is not personal financial product advice. Any advice contained in the Document is general advice only and has been prepared without considering your objectives, financial situation or needs. Before acting on any information, you should consider the appropriateness of the information provided and the nature of the relevant financial product having regard to your objectives, financial situation and needs. You should seek independent financial advice and read the relevant disclosure statements or other offer documents prior to making an investment decision about a financial product.

Hong Kong: Equities First Holdings Hong Kong Limited holds a Hong Kong Securities and Futures Commission Type 1 License and licensed in Hong Kong under the Money Lenders Ordinance (Money Lender’s Licence No. 1780/2022). This Document has not been reviewed by the Hong Kong Securities and Futures Commission. It is not intended as an offer to sell securities or a solicitation to buy any product managed or provided by Equities First Holdings Hong Kong Limited and is only intended for Professional Investors. This document is not directed to individuals or organizations for whom such offers or invitations would be unlawful or prohibited.

Korea: The foregoing is intended solely for professional financial consumers, professional investors or otherwise qualified investors who have sufficient knowledge and experience in entering into securities financing transactions. It is not intended for, and should not be used by, persons who do not meet that criteria.

United Kingdom: Equities First (London) Limited is authorised and regulated in the UK by the Financial Conduct Authority (“FCA”). In the UK, this Document is only being distributed and made available to persons of the kind described in Article 19(5) (investment professionals) and Article 49(2) (high net worth companies, unincorporated associations etc.) of Part IV of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (”FPO”) and any investment activity to which this presentation relates is only available to, and will only be engaged in with, such persons. Persons who do not have professional experience in matters relating to investment or who are not persons to whom Article 49 of the FPO applies should not rely on this document. This Document is only prepared for and available to persons who qualify as Professional Investors under the Markets in Financial Instruments Directive.

©2023 Equities First Holdings Hong Kong Limited. All rights reserved